Department of Obstetrics and Gynaecology

Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis (2021) Escala-Garcia M, Canisius S, Keeman R, Beesley J, Anton-Culver H, Arndt V, Augustinsson A, et al. Journal article AGO Algorithms for the Treatment of Breast Cancer: Update 2021 AGO-Algorithmen zur Behandlung von Brustkrebs: Update 2021 (2021) Schneeweiss A, Fasching P, Fehm T, Gerber B, Jackisch C, Loibl S, Schmidt M, et al. Journal article Brain and breast cancer cells with pten loss of function reveal enhanced durotaxis and rhob dependent amoeboid migration utilizing 3d scaffolds and aligned microfiber tracts (2021) Wieland A, Strissel P, Schorle H, Bakirci E, Janzen D, Beckmann M, Eckstein M, et al. Journal article AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update (2021) Friedrich M, Kühn T, Janni W, Müller V, Banys-Pachulowski M, Kolberg-Liedtke C, Jackisch C, et al. Journal article, Review article S2k-Leitlinie Diagnostik und Therapie der Endometriose – Anforderungen an die Pathologie (2021) Horn LC, Hohn AK, Burghaus S, Schafer SD, Ulrich UA, Schmidt D Journal article Mammographic density and prognosis in primary breast cancer patients (2021) Heindl F, Fasching P, Hein A, Hack C, Heusinger K, Gaß P, Pöschke P, et al. Journal article Digital Maternity Records: Motivation, Acceptance, Requirements, Usability and Prototype Evaluation of an Interface for Physicians and Midwives (2021) Dörflinger L, Nissen M, Jäger K, Wirth M, Titzmann A, Pontones C, Fasching P, et al. Conference contribution, Original article Metastatic cervical carcinoma: adenocarcinoma = squamous cell carcinoma? (2021) Hein A Conference contribution Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer-A Europe-Wide External Quality Assessment (2021) Erber R, Hartmann A, Fasching P, Rübner M, Stöhr R, Beckmann M, Zentgraf M, et al. Journal article Pattern of invasion in stage I mucinous ovarian cancer is prognostic within 2-years of diagnosis (2021) Meagher N, Koebel M, Anderson L, Tan A, Bolithon A, Anglesio M, Cohen P, et al. Conference contribution